The Study of Wound Dressings for Portable NPWT
NPWT
1 other identifier
interventional
57
1 country
1
Brief Summary
Introduction Negative pressure wound therapy (NPWT), also known as topical negative pressure, has become a popular therapy for the treatment of many acute and chronic wounds. In many randomized controlled trials(RCTs), NPWT also has benefit in diabetic foot ulcer and pressure ulcer. However, most studies used commercial VAC device in combined with polyurethane (PU) foam. It is not yet clear where NPWT combined with gauze as wound filler is as effective as the PU foam. This RCT evaluated the efficacy of the gauze and PU foam, two kinds of fillers routinely used in negative pressure wound therapy, on the healing of the diabetic lower-extremity ulcers and the pressure ulcer. Methods From 2010/1 to 2015/01, the in-patient persons with difficult to heal diabetic ulcer or Grade 4 pressure ulcer were enrolled. These patients were divided into two groups randomly. The letter of consent was signed by the patient or patient's family. After debridement of the infective wound, the wound of experimental group was packed with a moistened Polyhexamethylene biguamide (PHMB) impregnated gauze (Kerlix AMD, Covidien). A noncollapsible drainage tube (Blake drain, Ethicon) was applied to the wound, and then sealed with 3M Tegaderm Film. The system was connected to a 1-bottle water-seal chest drainage system and to standard wall suction at 125 mmHg negative pressure. The dressing was changed at 72- to 96-hour intervals (twice a week) for a period of 3 weeks. To the control group, the PU foam dressing from KCI was packed and sealed to the wound with the same continuous wall suction at -125mmHg. Investigators observed and recorded the ulcer area twice a week on each time of changing dressing in the following 3 weeks. The percentage of wound area reduction(PWAR) was used as a predictor of wound healing. The repeated measuring data were analyzed using linear mixed mode with SPSS statistical software. This clinical study was approved and monitored by Institutional Review Board of Show Chwan Memorial Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 4, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Posted
Study publicly available on registry
May 2, 2017
CompletedMay 2, 2017
April 1, 2017
3.9 years
November 4, 2015
April 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The reduction rate of pressure ulcer size
up to 3weeks
Secondary Outcomes (1)
The reduction rate of diabetic foot ulcer size
up to 3weeks
Study Arms (2)
foam
ACTIVE COMPARATORPU foam dressing from KCI
gauze
ACTIVE COMPARATORPolyhexamethylene biguamide (PHMB) impregnated gauze (Kerlix AMD, Covidien)
Interventions
a dressing or filler material is used to fit to the contours of a wound (which is covered with a non-adherent dressing film) .
Eligibility Criteria
You may qualify if:
- in-patient persons with the pressure ulcer or diabetic ulcer
You may not qualify if:
- Patient who has uncontrolled medical condition, such as sepsis, cellulitis
- Patient with diabetic ulcer who has severe PAOD untreated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tainan Municipal Hospital
Tainan, 701, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chao-Chin Yu, Master
Tainan Municipal Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2015
First Posted
May 2, 2017
Study Start
February 1, 2011
Primary Completion
January 1, 2015
Study Completion
March 1, 2016
Last Updated
May 2, 2017
Record last verified: 2017-04